Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne Brain

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
British Journal of Cancer|January 6, 2017
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survivalPauline Rochefort, Sylvie Chabaud, Jean-Yves Pierga, et al.
Breast (Edinburgh, Scotland)|June 4, 2026
EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer careFiorita Poulakaki, Etienne Brain, Icro Meattini, et al.
Breast Cancer Research and Treatment|May 19, 2010
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patientsJean-Yves Pierga, Suzette Delaloge, Marc Espié, et al.
Breast Cancer Research and Treatment|January 10, 2014
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, et al.
Ecancermedicalscience|October 21, 2020
Perspectives on cancer care in older patients in FranceMathilde Hauchecorne, Monica Pierro, Etienne Brain, et al.
Cancer Research and Treatment|December 29, 2017
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast CancerRenaud Sabatier, Véronique Diéras, Xavier Pivot, et al.
Cancer Epidemiology|November 27, 2024
Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimatesRicha Shah, Nicolò Matteo Luca Battisti, Etienne Brain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinomaYungan Tao, Keyvan Rezaï, Etienne Brain, et al.
Patient Education and Counseling|October 9, 2018
Preferences for surrogate designation and decision-making process in older versus younger adults with cancer: A comparative cross-sectional studyClaudia Martinez-Tapia, Florence Canoui-Poitrine, Philippe Caillet, et al.
Breast (Edinburgh, Scotland)|September 20, 2015
Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|January 6, 2017
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survivalPauline Rochefort, Sylvie Chabaud, Jean-Yves Pierga, et al.
Breast (Edinburgh, Scotland)|June 4, 2026
EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer careFiorita Poulakaki, Etienne Brain, Icro Meattini, et al.
Breast Cancer Research and Treatment|May 19, 2010
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patientsJean-Yves Pierga, Suzette Delaloge, Marc Espié, et al.
Breast Cancer Research and Treatment|January 10, 2014
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, et al.
Ecancermedicalscience|October 21, 2020
Perspectives on cancer care in older patients in FranceMathilde Hauchecorne, Monica Pierro, Etienne Brain, et al.
Cancer Research and Treatment|December 29, 2017
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast CancerRenaud Sabatier, Véronique Diéras, Xavier Pivot, et al.
Cancer Epidemiology|November 27, 2024
Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimatesRicha Shah, Nicolò Matteo Luca Battisti, Etienne Brain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinomaYungan Tao, Keyvan Rezaï, Etienne Brain, et al.
Patient Education and Counseling|October 9, 2018
Preferences for surrogate designation and decision-making process in older versus younger adults with cancer: A comparative cross-sectional studyClaudia Martinez-Tapia, Florence Canoui-Poitrine, Philippe Caillet, et al.
Breast (Edinburgh, Scotland)|September 20, 2015
Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, et al.
Pageof 14